EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Photodynamic priming ( PDP ) targets platinum resistance from chronic perfluoroalkyl substances ( PFAS ) exposure in ovarian cancer cells

Brittany P Rickard iD, Meghan M Dillon, Lauren A Sapienza-Lundie, Suzanne E Fenton, Imran Rizvi iD

Photochemistry and Photobiology · 2025

DOI: 10.1111/php.70048 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Photochemistry and Photobiology, 2025. Verfasst von Brittany P Rickard und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, North Carolina State University, Raleigh, North Carolina, USA. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Fluorocarbons, Drug Resistance, Neoplasm, Photochemotherapy. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIEHS NIH HHS, NC State Office of Research and Innovation, UNC-NC State Joint Department of Biomedical Engineering.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Photodynamic therapy (PDT) is a photochemistry‐based treatment modality that synergizes with traditional agents and can overcome chemoresistance. Eighty percent of ovarian cancer patients develop chemoresistant disease, highlighting the need to identify sources of treatment failure and develop rational combinations. Studies have shown that perfluoroalkyl substances (PFAS) induce chemoresistance in a duration‐dependent manner in OVCAR‐3 cells. PFAS are widespread drinking water contaminants present in the blood of nearly all Americans. The present study evaluated the ability of photodynamic priming (PDP), a sub‐cytotoxic variant of PDT, in combination with chemotherapy to overcome chemoresistance in two OVCAR‐3 cell cohorts: PFAS chronically‐exposed and outgrown (allowed to “recover” from chronic PFAS exposure). Effectiveness of benzoporphyrin derivative‐ (BPD‐) or aminolevulinic acid‐induced protoporphyrin IX‐PDP (ALA‐PpIX‐PDP) was assessed in combination with carboplatin and doxorubicin. In PFAS chronically‐exposed cells, BPD‐PDP + carboplatin reduced survival fraction compared to carboplatin alone. Mitochondrial membrane potential also decreased significantly in both cohorts following ALA‐PpIX‐PDP‐based combinations. PDP + doxorubicin also successfully overcame chemoresistance arising from chronic PFAS exposure but was less effective than PDP + carboplatin. Together, these findings demonstrate the efficacy of PDP‐based combinations in overcoming chronic PFAS exposure‐induced chemoresistance and should be explored in pre‐clinical models of ovarian cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsFluorocarbonsDrug Resistance, NeoplasmPhotochemotherapyPhotosensitizing AgentsFemaleHumansCell Line, Tumor

Stichwörter der Autor:innen

PFASmitochondriaovarian cancerphotodynamic therapyplatinumrecovery

Substanzen

FluorocarbonsPhotosensitizing Agents

Autor:innen und Institutionen

  • Department of Biological Sciences, North Carolina State University, Raleigh, North Carolina, USA.
  • Curriculum in Toxicology & Environmental Medicine, University of North Carolina School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Lampe Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Chapel Hill, North Carolina, USA.
  • Toxicology Program, Department of Biological Sciences, North Carolina State University, Raleigh, North Carolina, USA.
  • Center for Human Health and the Environment, North Carolina State University, Raleigh, North Carolina, USA.
  • Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.

ORCID-Profile: Brittany P Rickard, Imran Rizvi

Förderung

  • NIEHS NIH HHS
  • NC State Office of Research and Innovation
  • UNC-NC State Joint Department of Biomedical Engineering
  • NCI NIH HHS
  • National Institute of Environmental Health Sciences
  • National Cancer Institute

Zitieren

APA

Rickard, B. P., Dillon, M. M., Sapienza-Lundie, L. A., Fenton, S. E., & Rizvi, I. (2025). Photodynamic priming ( PDP ) targets platinum resistance from chronic perfluoroalkyl substances ( PFAS ) exposure in ovarian cancer cells. Photochemistry and Photobiology. https://doi.org/10.1111/php.70048

Vancouver

Rickard BP, Dillon MM, Sapienza-Lundie LA, Fenton SE, Rizvi I. Photodynamic priming ( PDP ) targets platinum resistance from chronic perfluoroalkyl substances ( PFAS ) exposure in ovarian cancer cells. Photochemistry and Photobiology. 2025. doi:10.1111/php.70048

BibTeX
@article{Rickard2025,
  author = {Rickard, Brittany P and Dillon, Meghan M and Sapienza-Lundie, Lauren A and Fenton, Suzanne E and Rizvi, Imran},
  title = {Photodynamic priming ( PDP ) targets platinum resistance from chronic perfluoroalkyl substances ( PFAS ) exposure in ovarian cancer cells},
  journal = {Photochemistry and Photobiology},
  year = {2025},
  doi = {10.1111/php.70048}
}
Kostenlos starten →